Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
Giorgia Radicioni, Agathe Ceppe, Amina A. Ford, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 11, pp. 1241-1254
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Physiology and pathophysiology of human airway mucus
David B. Hill, Brian Button, Michael Rubinstein, et al.
Physiological Reviews (2022) Vol. 102, Iss. 4, pp. 1757-1836
Open Access | Times Cited: 172
Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway
Yaoxing Chen, Chenyun Zhang, Yukun Huang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115196-115196
Closed Access | Times Cited: 40
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the “Chronic Obstructive Pulmonary Disease–Bronchiectasis Association”
Jeffrey Huang, Erin Cant, Holly R. Keir, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 4, pp. 417-426
Open Access | Times Cited: 61
Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B
Jerome Carpenter, Yang Wang, Richa Gupta, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 39
Open Access | Times Cited: 57
Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
Aran Singanayagam, Joseph Footitt, Matthias Marczynski, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 8
Open Access | Times Cited: 52
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers
Sang-Ryul Cha, Jimin Jang, Sung‐Min Park, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 41
Nasal airway transcriptome-wide association study of asthma reveals genetically driven mucus pathobiology
Satria P. Sajuthi, Jamie L. Everman, Nathan D. Jackson, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers
Rudra Pangeni, Tuo Meng, Sagun Poudel, et al.
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122661-122661
Open Access | Times Cited: 36
The combination of propylene glycol and vegetable glycerin e-cigarette aerosols induces airway inflammation and mucus hyperconcentration
Michael D. Kim, Samuel Chung, Nathalie Baumlin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in COPD
Kristopher Opron, Lesa Begley, John R. Erb‐Downward, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 2, pp. 186-200
Closed Access | Times Cited: 14
Physiological and immunological barriers in the lung
Takahiro Kageyama, Takashi Ito, Shigeru Tanaka, et al.
Seminars in Immunopathology (2024) Vol. 45, Iss. 4-6, pp. 533-547
Open Access | Times Cited: 14
Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Accelerated Lung Function Decline and Mucus–Microbe Evolution in Chronic Obstructive Pulmonary Disease
Oliver W. Meldrum, Gavin C. Donaldson, Jayanth Kumar Narayana, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 3, pp. 298-310
Open Access | Times Cited: 10
Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum
Weiwen Sun, Si Mou, Catherine Huntington, et al.
Bioanalysis (2025), pp. 1-12
Open Access | Times Cited: 1
Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease Persistence
Bethany D. Batson, Bryan Zorn, Giorgia Radicioni, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 67, Iss. 2, pp. 253-265
Open Access | Times Cited: 32
Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Stanislav Kotlyarov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 985-985
Open Access | Times Cited: 30
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
Rod Hughes, Eleni Rapsomaniki, Christer Janson, et al.
Respiratory Medicine (2022) Vol. 200, pp. 106921-106921
Open Access | Times Cited: 29
Air-Liquid interface cultures to model drug delivery through the mucociliary epithelial barrier
Rhianna E. Lee, Boris Reidel, Mark Nelson, et al.
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114866-114866
Open Access | Times Cited: 23
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease
Alex Kayongo, Nicole Robertson, Trishul Siddharthan, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 21
Periodontopathogens Porphyromonas gingivalis and Fusobacterium nucleatum and Their Roles in the Progression of Respiratory Diseases
Tao Shi, Jiale Wang, Jiajia Dong, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1110-1110
Open Access | Times Cited: 17
Mucin Glycans: A Target for Cancer Therapy
Lingbo Sun, Yuhan Zhang, Wenyan Li, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7033-7033
Open Access | Times Cited: 17
Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma
Xinyue Hu, Ying‐Chun Shen, Yilin Zhao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview
Liu-Ying Li, Chuantao Zhang, Fengya Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
Louisa L. Y. Chan, Danielle E. Anderson, Hong Sheng Cheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
E-Cigarette Use, Small Airway Fibrosis, and Constrictive Bronchiolitis
Lida P. Hariri, B. Flashner, David J. Kanarek, et al.
NEJM Evidence (2022) Vol. 1, Iss. 6
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top